Valuation: Harbin Gloria Pharmaceuticals Co., Ltd

Market Cap 6.47B 950M 834M 770M 711M 1.35B 91.01B 1.38B 9.25B 3.6B 44.54B 3.57B 3.49B 155B P/E 2024
24.2x
P/E 2025 18.2x
Enterprise Value 5.63B 827M 726M 670M 619M 1.17B 79.22B 1.2B 8.05B 3.13B 38.77B 3.11B 3.04B 135B EV / Sales 2024
2.12x
EV / Sales 2025 2.82x
Free-Float
90.63%
Yield 2024 *
-
Yield 2025 -
1 day-3.33%
1 week+7.41%
Current month+7.41%
1 month+2.84%
3 months-22.25%
6 months-7.64%
Current year-5.54%
1 week 2.84
Extreme 2.84
3.08
1 month 2.37
Extreme 2.37
3.08
Current year 2.37
Extreme 2.37
3.99
1 year 2.37
Extreme 2.37
4.08
3 years 1.66
Extreme 1.66
4.08
5 years 1.66
Extreme 1.66
4.08
10 years 1.66
Extreme 1.66
9.8
Manager TitleAgeSince
Chief Executive Officer 53 25/12/2022
Corporate Officer/Principal 42 17/04/2018
Corporate Officer/Principal 40 22/05/2019
Director TitleAgeSince
Director/Board Member 40 13/03/2025
Director/Board Member 53 10/11/2022
Director/Board Member 42 10/11/2022
Date Insider Type Main position Quantity % Market Cap.
01/07/25Sell 587,500 0.0283%
01/07/25Sell

Director

259,600 0.0125%
01/07/25Sell 587,500 0.0283%
Change 5-day change 1-year change 3-year change Capi.($)
-3.33%+7.41%-0.34%+39.42% 984M
-0.80%+1.38%+12.40%+82.31% 48.12B
-3.08%+3.29%+65.80%+113.96% 37.36B
-1.38%-2.29%-5.21%+40.28% 12.36B
-0.43%+3.18%+14.94%+97.17% 12.12B
+0.38%+4.19%+34.19%+123.08% 9.14B
-2.20%-0.91%+19.15%+43.83% 7.21B
+1.24%+4.23%+58.03%-1.50% 7.14B
-1.82%+0.88%+19.55%+222.63% 6.73B
-7.00%+12.89%-22.31%+10.09% 6.35B
Average -1.84%+2.07%+19.62%+77.13% 14.75B
Weighted average by Cap. -1.62%+3.16%+27.29%+87.63%

Financials

2024 2025
Net sales 2.44B 359M 315M 291M 268M 509M 34.35B 519M 3.49B 1.36B 16.81B 1.35B 1.32B 58.35B 2.14B 314M 275M 254M 235M 445M 30.05B 454M 3.06B 1.19B 14.71B 1.18B 1.15B 51.06B
Net income 233M 34.21M 30.01M 27.7M 25.6M 48.52M 3.28B 49.49M 333M 129M 1.6B 128M 126M 5.56B 377M 55.4M 48.59M 44.86M 41.45M 78.57M 5.3B 80.15M 539M 210M 2.6B 208M 203M 9.01B
Net Debt -509M -74.77M -65.58M -60.54M -55.95M -106M -7.16B -108M -728M -283M -3.5B -281M -275M -12.16B -838M -123M -108M -99.75M -92.18M -175M -11.79B -178M -1.2B -466M -5.77B -463M -452M -20.04B
Logo Harbin Gloria Pharmaceuticals Co., Ltd
HARBIN GLORIA PHARMACEUTICALS Co Ltd is a China-based company principally engaged in the research, development, production and sale of pharmaceuticals. The Company operates its businesses through three segments. The Traditional Chinese Medicine segment's main product is Annao Pills and Tablets. The Chemical Pharmaceuticals segment's products include cardiovascular and cerebrovascular drugs, musculoskeletal drugs, vitamins, electrolytes, analgesics, anti-infectives, anti-tumor drugs and others. The Others segment engages in pharmaceutical research and development, clinical services and others. The Company distributes its products within the domestic market and to overseas markets.
Employees
2,350
Date Price Change Volume
07/07/26 CN¥2.900 -3.33% 73,550,560
07/07/26 CN¥3.000 -0.99% 108,486,797
06/07/26 CN¥3.030 +2.36% 119,789,634
03/07/26 CN¥2.960 +0.68% 111,111,183
02/07/26 CN¥2.940 +2.08% 156,631,562

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002437 Stock